Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Thrombocytopenia 1Stomach Neoplasms 1Neutropenia 1Esophageal Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 592Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 508Specimen Handling 504Nivolumab 408Cisplatin 370Carboplatin 359Biopsy 304Blood Specimen Collection 295Radiosurgery 284Paclitaxel 274Surveys and Questionnaires 268Gemcitabine 267Standard of Care 266fludarabine 261Dexamethasone 258Drug Therapy 257venetoclax 247Bevacizumab 246Oxaliplatin 206Rituximab 196Capecitabine 196Radiation 189Fluorouracil 186Ipilimumab 185durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Algorithms × 1 year × Clear all
NCT04526886 2025-10-06

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Dartmouth-Hitchcock Medical Center

Phase NA Completed
52 enrolled 8 charts
Classical hematologyGastrointestinal

Appendiceal Neoplasms, Esophageal Neoplasms, Neutropenia, Stomach Neoplasms, Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡